Somatostatin receptor scintigraphy and somatostatin therapy in the evaluation and treatment of malignant thymoma.
作者信息
Lin K, Nguyen B D, Ettinger D S, Chin B B
机构信息
Department of Radiology and Radiological Sciences, Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA.
出版信息
Clin Nucl Med. 1999 Jan;24(1):24-8. doi: 10.1097/00003072-199901000-00006.
PURPOSE
This report illustrates the potential diagnostic and therapeutic utility of somatostatin receptor scintigraphy and therapy with somatostatin.
METHODS
In-111 pentetreotide (In-111 octreotide), a somatostatin analog, was used to define the receptor status and the extent of disease in a case of malignant thymoma.
RESULTS
Subsequent treatment with nonradioactive somatostatin inhibited tumor growth.
CONCLUSION
In-111 octreotide may be useful to define tumor receptor status and may provide prognostic information useful in determining subsequent therapy.
Zotero 插件